• LAST PRICE
    42.8600
  • TODAY'S CHANGE (%)
    Trending Down-0.0500 (-0.1165%)
  • Bid / Lots
    40.1100/ 1
  • Ask / Lots
    44.0800/ 1
  • Open / Previous Close
    43.4300 / 42.9100
  • Day Range
    Low 41.9050
    High 44.3700
  • 52 Week Range
    Low 21.2100
    High 75.0167
  • Volume
    380,260
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 42.92
TimeVolumeGPCR
09:32 ET244243.99
09:34 ET153544.0711
09:36 ET121143.93
09:38 ET133843.78
09:41 ET20043.18
09:45 ET10042.84
09:48 ET10043.0638
09:52 ET10042.83
09:56 ET50043.005
09:59 ET145342.72
10:01 ET43442.625
10:03 ET70042.87
10:06 ET161143
10:10 ET40043.035
10:12 ET45242.91
10:19 ET136843.01
10:24 ET30042.89
10:30 ET77442.97
10:32 ET915443.265
10:33 ET10043.245
10:37 ET42843.32
10:39 ET150043.37
10:42 ET30043.61
10:44 ET180143.79
10:46 ET290043.7375
10:48 ET10043.79
10:50 ET30043.94
10:51 ET226843.835
10:53 ET89744
11:00 ET10043.9
11:04 ET219543.815
11:06 ET70043.825
11:08 ET50043.625
11:09 ET20043.84
11:11 ET14043.765
11:13 ET10043.705
11:20 ET40043.93
11:24 ET95843.84
11:26 ET80343.87
11:27 ET10043.87
11:29 ET47943.88
11:31 ET203344.105
11:36 ET267043.98
11:38 ET20044.07
11:42 ET40043.97
11:44 ET50043.99
11:51 ET40043.87
11:54 ET10043.89
11:56 ET20043.91
12:02 ET908243.35
12:03 ET60043.465
12:05 ET63643.3
12:09 ET20043.26
12:14 ET20043.34
12:16 ET60343.13
12:18 ET20043.105
12:20 ET10043.04
12:21 ET10043.14
12:23 ET10042.965
12:25 ET97643.13
12:30 ET51243.185
12:32 ET2340243
12:34 ET1655342.95
12:36 ET5112142.845
12:38 ET10042.81
12:39 ET10042.92
12:41 ET473943
12:43 ET489043
12:45 ET10042.785
12:50 ET20042.735
12:54 ET30042.58
12:59 ET10042.595
01:06 ET67242.601
01:08 ET370442.5
01:10 ET76042.525
01:14 ET71942.39
01:17 ET134842.345
01:19 ET862442.11
01:21 ET60042.11
01:28 ET10042.03
01:30 ET31442.1
01:33 ET793441.905
01:35 ET10042
01:37 ET160042.04
01:42 ET80042.14
01:44 ET10042.135
01:46 ET21742.13
01:48 ET30042.1699
01:51 ET10042.125
01:53 ET40042.1125
01:57 ET40042.095
02:02 ET50042.16
02:06 ET40042.2
02:08 ET10042.19
02:18 ET50042.26
02:20 ET10042.32
02:22 ET10042.305
02:26 ET120042.43
02:29 ET30042.4225
02:33 ET1195842.815
02:36 ET20042.795
02:38 ET40042.8
02:42 ET1757042.96
02:44 ET170042.99
02:45 ET150042.91
02:47 ET210042.88
02:49 ET20042.915
02:54 ET268142.83
03:00 ET20042.96
03:02 ET40043.04
03:05 ET81043.1
03:07 ET20043.1
03:12 ET110043.15
03:14 ET16043.155
03:16 ET90043.14
03:18 ET156443.025
03:20 ET2950042.965
03:21 ET20042.94
03:25 ET30842.95
03:27 ET20042.96
03:30 ET60043.025
03:32 ET110042.8
03:34 ET60042.68
03:36 ET80042.755
03:41 ET130042.71
03:45 ET21742.735
03:48 ET125042.84
03:50 ET105042.78
03:52 ET140042.89
03:54 ET356543
03:56 ET475042.9
03:57 ET1506742.9
03:59 ET235042.86
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGPCR
Structure Therapeutics Inc
2.0B
-17.1x
---
United StatesSNDX
Syndax Pharmaceuticals Inc
2.0B
-8.0x
---
United StatesGERN
Geron Corp
1.9B
-10.2x
---
United StatesJANX
Janux Therapeutics Inc
1.9B
-28.1x
---
United StatesNMRA
Neumora Therapeutics Inc
2.2B
-5.9x
---
United StatesSANA
Sana Biotechnology Inc
2.2B
-6.8x
---
As of 2024-03-29

Company Information

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.

Contact Information

Headquarters
611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Daniel Welch
Chief Executive Officer, Director
Raymond Stevens
Chief Financial Officer
Jun Yoon
Chief Technology Officer
Yingli Ma
Chief Scientific Officer
Xichen Lin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.0B
Revenue (TTM)
$0.00
Shares Outstanding
46.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.51
Book Value
$9.76
P/E Ratio
-17.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.